Primecap Management CO Astrazeneca PLC Transaction History
Primecap Management CO
- $122 Billion
- Q2 2025
A detailed history of Primecap Management CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Primecap Management CO holds 41,200,091 shares of AZN stock, worth $3.1 Billion. This represents 2.35% of its overall portfolio holdings.
Number of Shares
41,200,091
Previous 40,661,485
1.32%
Holding current value
$3.1 Billion
Previous $2.99 Billion
3.67%
% of portfolio
2.35%
Previous 2.53%
Shares
32 transactions
Others Institutions Holding AZN
# of Institutions
1,414Shares Held
499MCall Options Held
7.24MPut Options Held
2.65M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
-
Franklin Resources Inc San Mateo, CA21.3MShares$1.6 Billion0.42% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...